Medication event monitoring

Fig. 1. Electronic medication event monitor in the process of communicating stored data from monitor to computer. The transfer occurs without wire connection between the inverted monitor and the communications interface device, which transfers data to MS-DOS-based computers via serial port. A second medication event monitor, with a somewhat larger container size, stands nearby. (Copyright, 1994, APREX Corporation reproduced with permission.)...

Urquhart J. 1997. The electronic medication event monitor - lessons for pharmacotherapy . Clin. Phar-macokinet. 32 345-356. 

J. R. Matsuyama, B. J. Mason, and S. G. Jue, Pharmacists interventions using an electronic medication-event monitoring device s adherence data versus pill counts. Ann Pharmacother 27 851-855 (1993). 

Matsui D, Hermann C, Braudo M et al (1992) Clinical use of the Medication Event Monitoring System a new window into pediatric compliance. Clin Pharmacol Ther 52 102-3. 

Adverse-events monitoring parameters (Table 52-7) Medications used for comorbidities ... 

Patients should always start with the lowest recommended dose and increase slowly to avoid overdosing. Follow-up with the patient is necessary to evaluate whether the dietary supplement is safe and effective. Report any suspected adverse event to FDA s Medwatch, 1-800-FDA-1088. FDA has developed the Special Nutritionals Adverse Event Monitoring System (SN/AEMS), a database of adverse events associated with the use of special nutritional products dietary supplements, infant formulas, and medical foods. ... 

MedWatch program. The FDA recently established the Special Nutritionals Adverse Event Monitoring System, a searchable database including information about suspected adverse events associated with dietary supplements or nutritional products. This database includes reports that have been submitted to MedWatch and can be accessed via the Internet (http //vm.cfsan.fda.gov/ dms/ aems.html). Continued efforts by health-care professionals to recognize and report suspected interactions between prescription medications and herbal and other alternative therapies should ultimately increase knowledge and awareness of interactions and improve the quality of patient care (see Heck et al., 2000 Izzo, 2004 Butterweck, 2004 Chan, 2005). 

The medication use process is a complex system intended to optimize patient outcomes within organizational constraints. Quality medication use involves selection of the optimal drug, avoidance of adverse medication events, and completion of the therapeutic objective. Safe medication practices focus on the avoidance of medication errors. Medication use review and ongoing medication monitoring activities focus on optimizing medication selection and use. These two approaches are important means of assessing and optimizing the quality of medication use. 

Handler, S. M., Altman, R. L., Perera, S., Hanlon, J. T., Studenski, S. A, Bost, J. E., et al. (2007 Jul-Aug). A systematic review of the performance characteristics of clinical event monitor signals used to detect adverse drug events in the hospital setting. Journal of the American Medical Informatics Association JAMIA, 14(4), 451-458. 

Because nearly 70% of patients who use alternative therapies do not inform their health-care providers about these products, pharmacists and other health-care professionals should question all patients about their use of alternative therapies. Health-care professionals should remain vigilant for potential interactions between alternative therapies and prescription medications, especially medications with a narrow therapeutic index, and should report suspected interactions to the FDA MedWatch program. The FDA recently established the Special Nutritionals Adverse Event Monitoring System, a searchable database including information about... 

This organization was founded in 1989 to monitor anesthesia errors and was expanded to patient incident reporting and monitoring after the findings of the Quality in Australian Health Care Study (QAHCS) in 1995 [9]. Adverse medical events are reported and analyzed through its subsidiary known as Patient Safety International (PSI), using the Advanced Incident Management System (AIMS), a software tool. 

Public health surveillance, the first component of the template, should operate continuously to improve the chances for the quick detection of unusual medical events in the local population. As part of the medical surveillance systems, several communities are currently monitoring hospital admissions, 911 calls, and unexplained deaths. Once an anomaly is detected, a medical diagnosis must be made to identify and confirm its cause. If a specific disease is confirmed, the public health community will most likely undertake an epidemiological investigation to determine the disffibution of cases and the source or sources of the outbreak. 

To ensure that an operation is under control may necessitate atmospheric monitoring this is summarized in Chapter 9. General safety considerations, administration and systems of work requirements, including elementary first aid, are summarized in Chapter 11. For example, the recommended strategy is to include provision for appropriate first aid procedures within the system of work before specific chemicals are brought into use to so order work practices that the risk of exposure is minimized and in the event of an accident involving any but the most trivial injuries — with no foreseeable likelihood of complications or deterioration — to seek immediate medical assistance. 

Monitor for adverse events from medications, including candidiasis and dysphonia from inhaled corticosteroids. 

---